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Porcine circovirus associated disease (PCVD) is responsible for a significant economic loss in the livestock
industry. A vaccine based on a viral antigen has been developed to prevent this disease, and it is produced
industrially in the pig’s kidney cell line PK15. However, both biomass and viral antigen production are limited in
the current attachment culture bioprocess set-up.
The aim of this work is to improve PCVD vaccine production through the adaptation of PK15 cells to suspension
culture, the introduction of changes in culture operation and the improvement of specific viral antigen
productivity through media design.
The suspension culture of PK15 cells was achieved by means of a progressive cell adaptation process. Cells
grown in suspension maintained a viability above 90% and a cell density equivalent to 0.7 times of that achieved
in the original adherent culture.
Pseudo perfusion cultures were carried out using a 1 vvd rate, increasing the maximum cell density achieved to
8 times the base suspension culture. Feeding media was designed to decrease the perfusion rate to 0.1 vvd
using the specific nutrient requirements of the cells determined experimentally. Results obtained at this higher
density lower perfusion rate culture were comparable with those achieved at a 1 vvd rate in terms of biomass
production.
A feeding strategy and feeding media composition was developed using a model-based platform CELIA (Cell
culturE medIA optimization platform) that considers cell composition and metabolic requirements of the cells in
culture. An increase of a 150% in biomass production was obtained using optimized feeding when compared to
batch culture.
Viral antigen production data shows that even though total production increases significantly in all modes,
specific productivity is lower when higher cell densities are achieved. Further research is required to optimize
both the overall and specific productivity of the system.
Results show that it is possible to grow PK15 cells in suspension and to significantly increase the cell density
obtained using perfusion culture and model-based media optimization tools that consider the cell’s specific
nutritional requirements. These findings will be validated in a semi-industrial setting model before transferring
them to the industrial productive set-up.
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